BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kirundi J, Moghadamrad S, Urbaniak C. Microbiome-liver crosstalk: A multihit therapeutic target for liver disease. World J Gastroenterol 2023; 29(11): 1651-1668 [PMID: 37077519 DOI: 10.3748/wjg.v29.i11.1651]
URL: https://www.wjgnet.com/1007-9327/full/v29/i11/1651.htm
Number Citing Articles
1
Yana V. Kiseleva, Tatiana S. Zharikova, Roman V. Maslennikov, Shikhsaid M. Temirbekov, Anna V. Olsufieva, Olga L. Polyakova, André Pontes-Silva, Yury O. Zharikov. Gut Microbiota and Liver Regeneration: A Synthesis of Evidence on Structural Changes and Physiological MechanismsJournal of Clinical and Experimental Hepatology 2024; 14(6): 101455 doi: 10.1016/j.jceh.2024.101455
2
Sepp Fegerl. Prävention und Therapie viraler Epidemien2024; : 139 doi: 10.1007/978-3-662-67508-3_8
3
Yang Yang, Linjie Lv, Shanshan Shi, Gaofeng Cai, Lin Yu, Shuwen Xu, Tianyu Zhu, Xinyue Su, Ningning Mao, Yue Zhang, Song Peng, Jin He, Zhenguang Liu, Deyun Wang. Polysaccharide from walnut green husk alleviates liver inflammation and gluconeogenesis dysfunction by altering gut microbiota in ochratoxin A-induced miceCarbohydrate Polymers 2023; 322: 121362 doi: 10.1016/j.carbpol.2023.121362
4
Kendra A. Klag, Rickesha Bell, Xuan Jia, Alexandra Seguin, J. Alan Maschek, Mary Bronner, James E. Cox, June L. Round, Diane M. Ward. Low-Iron Diet-Induced Fatty Liver Development Is Microbiota Dependent and Exacerbated by Loss of the Mitochondrial Iron Importer Mitoferrin2Nutrients 2024; 16(12): 1804 doi: 10.3390/nu16121804
5
Ying Tian, Yuan Xie, Xinyu Hong, Zaixin Guo, Qi Yu. 17β-Estradiol protects female rats from bilateral oophorectomy-induced nonalcoholic fatty liver disease induced by improving linoleic acid metabolism alteration and gut microbiota disturbanceHeliyon 2024; 10(7): e29013 doi: 10.1016/j.heliyon.2024.e29013
6
Sadegh Mozaffari, Mahdeyeh Aliari, Solaleh Emamgholipour, Hossein Hosseini, Pedram Rezaei Amirkiasar, Mina Zare, Niki Katsiki, Ghodratollah Panahi, Amirhossein Sahebkar. The effect of probiotic consumption on lipid profile, glycemic index, inflammatory markers, and liver function in NAFLD patients: A systematic review and meta-analysis of randomized controlled trialsJournal of Diabetes and its Complications 2024; 38(8): 108780 doi: 10.1016/j.jdiacomp.2024.108780
7
Heng Yuan, Eun-Soo Jung, Soo-Wan Chae, Su-Jin Jung, James W. Daily, Sunmin Park. Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-OmicsNutrients 2024; 16(18): 3061 doi: 10.3390/nu16183061
8
E. G. Malaeva, I. O. Stoma. Microbiota and Long-Term Prognosis in Liver CirrhosisThe Russian Archives of Internal Medicine 2024; 14(3): 213 doi: 10.20514/2226-6704-2024-14-3-213-220
9
Aleksandra Białczyk, Alicja Rajewska, Roman Junik, Szymon Suwała. The Role of Probiotics in Managing Metabolic-Associated Fatty Liver Disease: An Updated ReviewCurrent Research in Nutrition and Food Science Journal 2024; 12(2): 490 doi: 10.12944/CRNFSJ.12.2.2
10
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
11
Mengqi Liu, William C. Cho, Robin J. Flynn, Xiaoliang Jin, Houhui Song, Yadong Zheng. microRNAs in parasite-induced liver fibrosis: from mechanisms to diagnostics and therapeuticsTrends in Parasitology 2023; 39(10): 859 doi: 10.1016/j.pt.2023.07.001
12
Wolfgang Reindl. Das intestinale Mikrobiom bei gastroenterologischen KrankheitsbildernGastroenterologie up2date 2023; 19(04): 385 doi: 10.1055/a-1824-0120
13
Olesya V. Pervishko, Maria D. Ardatskaya, Irina N. Zakharova, Natalia G. Soboleva, Ulyana A. Stinskaya, Irina V. Berezhnaya, Svetlana N. Borzakova, Diana K. Dmitrieva. The role of short-chain fatty acids in the formation of non-alcoholic fatty liver disease in children: A reviewPediatrics. Consilium Medicum 2024; (1): 76 doi: 10.26442/26586630.2024.1.202778